mMgl1 Inhibitors
Chemical inhibitors of mMgl1 can interact with various signaling pathways to inhibit the protein's function. LY294002 and Wortmannin, as inhibitors of phosphoinositide 3-kinases (PI3K), can disrupt the PI3K/Akt pathway, which is crucial for many cellular processes that mMgl1 may be involved in. The inhibition of PI3K activity by these chemicals can lead to a decrease in the phosphorylation and activation of downstream targets that are essential for mMgl1's role in cellular signaling. Similarly, U0126 and PD98059 target the MEK1/2 enzymes, leading to the suppression of the MAPK/ERK pathway. This pathway is often implicated in the regulation of cell cycle progression and apoptosis, processes that mMgl1 is associated with. By inhibiting MEK activity, these chemicals can prevent the activation of ERK and subsequent signaling events necessary for mMgl1 function.
Furthermore, SB203580, as a p38 MAP kinase inhibitor, can disrupt the signaling related to stress responses where mMgl1 may play a part. The interference with p38 MAP kinase activity by SB203580 can halt the transmission of signals required for mMgl1's involvement in cellular responses to stress. Rapamycin, by inhibiting mTOR, can affect the mTOR signaling pathway, which mMgl1 may utilize for regulating cell growth and proliferation. The blockade of mTOR by rapamycin can lead to a reduction in the signaling required for mMgl1's role in these processes. Additionally, SP600125, by inhibiting JNK, can affect apoptosis pathways, whereas LY83583, by reducing cyclic GMP levels, can influence signaling pathways that mMgl1 might be part of. PP2, through its selective inhibition of Src family tyrosine kinases, can disrupt the kinase-dependent signaling cascades that mMgl1 is engaged in. PD173074 targets FGFR tyrosine kinase activity, which can be involved in the signaling pathways of mMgl1, leading to the attenuation of its function. Lastly, Y-27632 and Go6976 inhibit ROCK and PKC respectively, which are enzymes that can regulate various cellular functions including those associated with mMgl1, thereby leading to the inhibition of mMgl1's activity in these pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks), which are involved in various signaling pathways, including those regulating cell growth and survival. Inhibition of PI3K can disrupt the downstream signaling required for the functional activity of mMgl1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 selectively inhibits MEK1 and MEK2, which are upstream regulators of the ERK pathway. Since mMgl1 is involved in pathways associated with cellular proliferation and apoptosis, U0126 can lead to the functional inhibition of mMgl1 by preventing its downstream signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase, involved in inflammatory responses and stress-induced signaling. By inhibiting p38 MAP kinase, SB203580 can disrupt the signaling pathways that mMgl1 is engaged in, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt the mTOR signaling pathway, which is crucial for cell growth and proliferation. Given that mMgl1 operates within these cellular processes, rapamycin can inhibit the functionality of mMgl1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which blocks the activation of MAPK/ERK. This inhibition can disrupt the signaling pathways mMgl1 is involved in, particularly those related to cell cycle regulation and apoptosis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which influences cellular processes such as apoptosis. By inhibiting JNK, SP600125 can affect the pathways that mMgl1 is part of, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, wortmannin can disrupt the pathways that influence the activity of mMgl1, leading to functional inhibition of the protein. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases, which are involved in various signaling pathways. By inhibiting these kinases, PP2 can disrupt the signaling cascades that are essential for mMgl1 activity. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
PD173074 is an inhibitor of the FGFR tyrosine kinase, which can play a role in the signaling pathways mMgl1 is involved in. Inhibition of FGFR can lead to functional inhibition of mMgl1 by disrupting its signaling network. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits the Rho-associated protein kinase (ROCK), which is implicated in various cellular functions including contraction, motility, and proliferation. Inhibition of ROCK can lead to the disruption of pathways essential for mMgl1 function. | ||||||